There is currently no universally established or medically approved daily fisetin dosage for healthy adults.
That is the most direct evidence-based answer to how much fisetin should I take daily. What exists today is a mix of commercial serving sizes, small human pilot studies, registered clinical trials, and a few completed human studies using very different schedules. Those sources do not converge on one medically validated daily amount for the general public. ClinicalTrials.gov: NCT07195318 PubMed PMID 39269340
If you want the broader context first, see the main fisetin dosage research summary, which collects the main regimens appearing across the literature.
Why there is no official standard daily dosage
There are two main reasons no official daily standard exists. First, the human evidence base is still small and inconsistent. Registered trials are testing different goals, populations, schedules, and dose formats. Some use 100 mg fisetin daily, some use 500 mg fisetin daily for limited periods, and some use short weight-based regimens like 20 mg/kg/day for two consecutive days instead of everyday intake. That kind of heterogeneity makes it hard to define one "correct" daily amount. ClinicalTrials.gov: NCT07195318 ClinicalTrials.gov: NCT04770064 ClinicalTrials.gov: NCT06431932
Second, even the researchers running human trials acknowledge that the evidence for beneficial effects, effective doses, and safety profiles in humans is extremely limited. The ClinicalTrials.gov record for the healthy-aging study explicitly says that most claims in this area come from preclinical research and that human evidence remains sparse. It also notes that supplement quality and active content can vary. That is not the language of a settled dosage standard. ClinicalTrials.gov: NCT07195318
Label serving sizes are not the same as proven effective doses
A major source of confusion is the difference between a label serving size and a proven effective dose. A label amount is simply what a manufacturer has chosen to sell and describe on a product page. A proven effective dose, by contrast, would need consistent support from well-designed human studies showing benefit and acceptable safety for a defined population and use case.
Those two things are not interchangeable. A product label can say 100 mg, 500 mg, or something higher, but that does not mean the amount is medically validated. It also does not mean the formulation matches what was used in a study. Some commercial products are single-ingredient fisetin; others are blends that combine fisetin with quercetin, resveratrol, green tea extract, or other compounds, making "how much fisetin per day" even harder to compare across labels. Amazon example: Double Wood 100 mg Amazon example: Toniiq 500 mg Amazon example: Lilicare blended 1200 mg formula
Common commercial label amounts
The table below shows illustrative retail label amounts, not medically validated intakes.
| Commercial example | Label amount | Type of product | Why it should be interpreted cautiously |
|---|---|---|---|
| Double Wood Fisetin | 100 mg | Single-ingredient fisetin product | Label amount is a marketplace choice, not proof of clinical effectiveness |
| Toniiq Fisetin | 500 mg | Single-ingredient fisetin product | Higher label amount does not automatically mean better evidence |
| Lilicare Fisetin blend | 1200 mg | Multi-ingredient formula | Blend total is not directly comparable with pure-fisetin products |
Retail listings like these show why fisetin supplement dosage can look confusing online: the numbers vary, and some products are blends rather than directly comparable fisetin-only preparations. Amazon example: Double Wood 100 mg Amazon example: Toniiq 500 mg Amazon example: Lilicare blended 1200 mg formula
What daily doses have actually been tested in humans
When readers ask about recommended fisetin dosage, the most useful place to look is human research rather than labels.
A current registered healthy-aging trial, NCT07195318, is testing 100 mg daily for 7 weeks in relatively healthy middle-aged and older adults. This is a randomized, placebo-controlled design aimed at safety and anti-inflammatory or general-health measures. It is a real human daily-use protocol, but it is still a study schedule, not a public dosage standard. ClinicalTrials.gov: NCT07195318
Another registered trial, NCT04770064, includes a 100 mg daily for 90 days arm in adults with knee osteoarthritis. That again shows that daily fisetin use is being studied, but in a disease-specific trial rather than as a general wellness standard for healthy adults. ClinicalTrials.gov: NCT04770064
A published 2024 pilot study in healthy adults over 50 used 500 mg daily for one week per month for six months. That schedule is often quoted online, but it is important to read it carefully. It was not continuous year-round daily use; it was a repeating monthly block. The study reported mixed results and stated that taking fisetin as an anti-aging agent was not recommended until more extensive studies are done. No adverse effects were noted in the small 10-person sample, but that does not establish a general daily dosage or long-term safety standard. PubMed PMID 39269340
A completed placebo-controlled crossover trial in Gulf War Illness also tested fisetin during repeated treatment periods, but fisetin did not reduce symptom severity more than placebo. That is important because it shows that merely appearing in human research does not mean a fisetin regimen has been clinically confirmed as effective. PubMed PMID 33802381
Daily-use human studies and completed trials compared
| Evidence type | Schedule | Population | What it shows |
|---|---|---|---|
| Registered clinical trial | 100 mg daily for 7 weeks | Relatively healthy middle-aged and older adults | Daily fisetin is being studied, but not established as standard |
| Registered clinical trial | 100 mg daily for 90 days | Adults with knee osteoarthritis | Sustained daily dosing can be tested against other schedules |
| Published pilot study | 500 mg daily for 1 week per month for 6 months | Healthy adults over 50 | Small human study with mixed results; not a standard daily rule |
| Completed randomized crossover trial | Repeated lower- and higher-dose treatment periods | Male veterans with Gulf War Illness | Fisetin did not outperform placebo |
ClinicalTrials.gov: NCT07195318 ClinicalTrials.gov: NCT04770064 PubMed PMID 39269340 PubMed PMID 33802381
High-dose, short-duration clinical protocols are a different question
One reason the daily-dose conversation becomes confusing is that fisetin research also includes weight-based, short-duration protocols that are not meant to function like normal daily supplement use.
For example, NCT06431932 describes oral fisetin at 20 mg/kg/day for two consecutive days in healthy volunteers and older adults. NCT06133634 uses 2 mg/kg/day in two three-day dosing periods separated by two weeks. The AFFIRM trial, NCT03430037, uses 20 mg/kg/day for 2 consecutive days, for 2 consecutive months. These are structured research protocols, not ordinary everyday label instructions. ClinicalTrials.gov: NCT06431932 ClinicalTrials.gov: NCT06133634 ClinicalTrials.gov: NCT03430037
That distinction matters because many readers see a phrase like "20 mg/kg/day" and treat it as if it answers how much fisetin per day for everyone. It does not. A weight-based short-burst protocol is asking a different scientific question than a fixed daily supplement schedule.
Weight-based trial protocols
| Trial protocol | Dose format | Schedule | Why it is not directly comparable to a daily label |
|---|---|---|---|
| NCT06431932 | 20 mg/kg/day | 2 consecutive days | Short pulse, weight-based, study-specific |
| NCT06133634 | 2 mg/kg/day | Two 3-day periods separated by 2 weeks | Intermittent, weight-based research schedule |
| NCT03430037 | 20 mg/kg/day | 2 consecutive days for 2 consecutive months | Repeated pulse design, not daily maintenance |
| NCT04770064 high-dose arm | ~20 mg/kg | 2 days, 28-day washout, then 2 days | Direct contrast with sustained daily dosing |
ClinicalTrials.gov: NCT06431932 ClinicalTrials.gov: NCT06133634 ClinicalTrials.gov: NCT03430037 ClinicalTrials.gov: NCT04770064
Why 100 mg, 500 mg, and weight-based amounts cannot be directly compared
At first glance, 100 mg fisetin daily, 500 mg fisetin daily, and 20 mg/kg/day all look like simple dose numbers. In practice, they are not directly comparable.
The first reason is schedule. 100 mg daily for 90 days is a continuous-exposure design. 500 mg daily for one week per month is a repeated monthly design. 20 mg/kg/day for 2 consecutive days is a short pulse. Even if two schedules produced the same cumulative milligram total over time, they would still represent different exposure patterns. ClinicalTrials.gov: NCT04770064 PubMed PMID 39269340
The second reason is dose format. Weight-based dosing changes with body mass, while fixed dosing does not. A 20 mg/kg regimen could translate into very different total milligram amounts depending on body weight. That means a number like "500 mg" cannot simply be lined up against "20 mg/kg" without first knowing the participant's weight and the exact schedule. ClinicalTrials.gov: NCT06431932
The third reason is study context. A disease-specific osteoarthritis trial, a healthy-aging pilot, and a vascular-function study are not testing the same question in the same population. That alone limits simple dose comparisons. ClinicalTrials.gov: NCT04770064 ClinicalTrials.gov: NCT07195318 ClinicalTrials.gov: NCT06133634
What is known about long-term safety
The honest answer is that long-term fisetin use remains insufficiently characterized in humans. The most relevant small human data point is the 2024 pilot study that used 500 mg daily for one week per month for six months and reported no adverse effects in 10 participants. But a 10-person pilot with mixed results is not enough to establish broad long-term safety. PubMed PMID 39269340
Registered studies lasting 7 weeks and 90 days help show that researchers are investigating longer exposure windows, but registry entries are not the same thing as mature published safety evidence. The Gulf War Illness crossover trial also reminds us that larger, more definitive trials are still needed to determine efficacy, durability, safety, and optimal dosage. ClinicalTrials.gov: NCT07195318 ClinicalTrials.gov: NCT04770064 PubMed PMID 33802381
Variables that may affect risk
Even without giving a recommended amount, it is clear that risk is unlikely to depend on milligrams alone. Trial eligibility criteria repeatedly point to factors such as liver disease, kidney disease, medication burden, age, anticoagulant use, and underlying health conditions. The AFFIRM trial, for example, excludes a long list of medications and medical situations around fisetin dosing. ClinicalTrials.gov: NCT03430037
Formulation also matters. The healthy-aging trial explicitly notes that supplement quality and actual active content may vary across commercial products. So the same label number may not guarantee the same exposure or composition in practice. ClinicalTrials.gov: NCT07195318
Questions to discuss with a qualified healthcare professional
For readers who still want a practical framework, the safest evidence-based approach is not to infer a daily dose from internet summaries, but to clarify the right questions. Reasonable discussion points with a qualified clinician include: whether the goal is general wellness versus participation in a monitored study; whether the product is single-ingredient fisetin or a blend; whether there are medications or anticoagulants that complicate use; whether liver, kidney, or gastrointestinal issues matter; whether a daily schedule is being confused with a short experimental pulse protocol; and whether there is any meaningful evidence for the specific outcome being sought in a person with that health profile. The point of these questions is not to imply a hidden correct dose, but to show why the answer is more complex than one number on a label. ClinicalTrials.gov: NCT03430037 ClinicalTrials.gov: NCT07195318
FAQ
How much fisetin should I take daily?
There is currently no universally established or medically approved daily fisetin dosage for healthy adults.
Is there a recommended fisetin dosage?
Not in the sense of a settled, medically validated public standard. What exists are commercial serving sizes and study regimens, not one universally recommended amount. ClinicalTrials.gov: NCT07195318
What is a common fisetin daily dosage on supplement labels?
Retail listings commonly show figures such as 100 mg and 500 mg, but these are label amounts, not proof of medically validated dosing. Amazon example: Double Wood 100 mg Amazon example: Toniiq 500 mg
Has 100 mg fisetin daily been studied?
Yes. Registered trials include 100 mg daily for 7 weeks and 100 mg daily for 90 days in specific study settings. ClinicalTrials.gov: NCT07195318 ClinicalTrials.gov: NCT04770064
Has 500 mg fisetin daily been studied?
A published pilot study used 500 mg daily for one week per month for six months, but that was not continuous everyday use and the study reported mixed findings. PubMed PMID 39269340
Are weight-based fisetin protocols the same as daily supplement use?
No. A protocol like 20 mg/kg/day for two consecutive days is a study design, not the same thing as routine everyday supplementation. ClinicalTrials.gov: NCT06431932
Is long-term fisetin use proven safe?
No. Long-term human safety is not yet well established. Small and ongoing studies provide some data, but not enough for a broad safety conclusion. PubMed PMID 39269340 ClinicalTrials.gov: NCT07195318
Why can't I compare 100 mg, 500 mg, and 20 mg/kg directly?
Because schedule, body weight, population, and study design all differ. Fixed daily amounts and weight-based pulse protocols are not interchangeable.
Does a supplement label prove an effective dose?
No. A label serving size is a commercial decision. It does not by itself establish efficacy or medical appropriateness.
Bottom line
If someone asks, how much fisetin should I take daily, the evidence-based answer remains cautious: there is no universally established or medically approved daily fisetin dosage for healthy adults. Human research has tested daily low-dose schedules, repeating monthly schedules, and short weight-based pulse protocols, but those are different study designs rather than one agreed rule. Commercial labels may show 100 mg, 500 mg, or higher blended totals, but label amounts are not the same as proven effective doses. ClinicalTrials.gov: NCT07195318 ClinicalTrials.gov: NCT04770064 ClinicalTrials.gov: NCT06431932 PubMed PMID 39269340 PubMed PMID 33802381
The most accurate conclusion today is not a number. It is a limitation: the research is still too early, too varied, and too context-dependent to manufacture a single recommended fisetin dosage from the available evidence.
This article is intended for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making significant changes to your diet, exercise routine, or supplement regimen, especially if you have an existing medical condition, are pregnant or breastfeeding, or take prescription medications.